✦ LIBER ✦

Exebryl-1: A novel small molecule currently in human clinical trials as a disease-modifying drug for the treatment of Alzheimer's disease

✍ Scribed by Snow, Alan D.; Cummings, Joel; Lake, Thomas; Hu, Qubai; Esposito, Luke; Cam, Judy; Hudson, Michael; Smith, Elizabeth; Runnels, Steve

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carvedilol as a Potential Novel Disease

✍ Pasinetti, Giulio; Rosen, Zohn; Rosenberg, Paul; Wang, Jun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Novel small-molecule inhibitors of casei

✍ Pike, Ian; Lahert, Emma; Russell, Claire; Ward, Malcolm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Preclinical and early clinical studies o

✍ Lavrovsky, Yan; Ivachtchenko, Alexander V.; Morozova, M.; Salimov, R.M.; Kasey, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Evaluation of the pons as a reference re

✍ Margolin, Richard; Schmidt, Mark; Gregg, Keith; Les, Andrea; Hill, Derek; Koeppe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Preclinical and Phase 1 clinical charact

✍ Allen J. Sedman; Howard Bockbrader; Roy D. Schwarz 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 445 KB

Why as a Medicinal Chemist I Am Not Opti

✍ Prof. Dr. Jean-Louis Kraus 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB